Lic Mf Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 30-09-2026
NAV ₹32.9(R) -2.66% ₹36.48(D) -2.66%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 13.39% 19.43% -% -% -%
Direct 14.9% 20.95% -% -% -%
Benchmark
SIP (XIRR) Regular 19.22% 13.74% -% -% -%
Direct 20.82% 15.22% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 86 Cr
Top Pharma Fund
Fund Name Rank Rating
SBI Healthcare Opportunities Fund -
UTI Healthcare Fund -
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
DSP Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -
Mirae Asset Healthcare Fund -
Nippon India Pharma Fund -
Tata India Pharma & Healthcare Fund -

NAV Date: 30-09-2026

Scheme Name NAV Rupee Change Percent Change
LIC MF Healthcare Fund-Regular Plan-Growth 32.9
-0.9000
-2.6600%
LIC MF Healthcare Fund-Regular Plan-IDCW 32.9
-0.9000
-2.6600%
LIC MF Healthcare Fund-Direct Plan-IDCW 36.46
-0.9900
-2.6600%
LIC MF Healthcare Fund-Direct Plan-Growth 36.48
-1.0000
-2.6600%

Review Date: 30-09-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -5.29 -2.75
-3.67
-5.29 | -1.85 17 | 17 Poor
3M Return % 3.31 4.65
2.82
-1.56 | 5.47 8 | 17 Good
6M Return % 20.34 19.34
21.01
14.32 | 27.55 10 | 17 Good
1Y Return % 13.39 23.98
17.84
7.91 | 27.76 12 | 16 Average
3Y Return % 19.43 20.48
19.28
16.68 | 21.69 5 | 10 Good
1Y SIP Return % 19.22
22.87
10.43 | 35.54 12 | 16 Average
3Y SIP Return % 13.74
13.75
9.92 | 17.45 6 | 10 Good
Return data last Updated On : Sept. 30, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -5.18 -2.75 -3.57 -5.18 | -1.73 17 | 17 Poor
3M Return % 3.65 4.65 3.16 -1.37 | 5.93 8 | 17 Good
6M Return % 21.13 19.34 21.84 14.81 | 28.55 10 | 17 Good
1Y Return % 14.90 23.98 19.45 9.46 | 29.80 12 | 16 Average
3Y Return % 20.95 20.48 20.74 17.73 | 22.95 5 | 10 Good
1Y SIP Return % 20.82 24.48 11.42 | 37.66 11 | 15 Average
3Y SIP Return % 15.22 14.84 11.55 | 18.65 5 | 9 Good
Return data last Updated On : Sept. 30, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Lic Mf Healthcare Fund NAV Regular Growth Lic Mf Healthcare Fund NAV Direct Growth
30-09-2026 32.898 36.4768
29-09-2026 33.7967 37.4719
28-09-2026 33.8667 37.5481
25-09-2026 34.293 38.0167
24-09-2026 34.3049 38.0286
23-09-2026 34.5081 38.2525
22-09-2026 34.245 37.9595
21-09-2026 34.4272 38.1601
18-09-2026 34.2338 37.9417
17-09-2026 33.9152 37.5872
16-09-2026 33.4995 37.1252
15-09-2026 33.5578 37.1885
11-09-2026 34.173 37.8649
10-09-2026 34.3518 38.0616
09-09-2026 34.5486 38.2783
08-09-2026 34.5995 38.3333
07-09-2026 34.3193 38.0215
04-09-2026 34.1109 37.7866
03-09-2026 34.3019 37.9969
02-09-2026 34.2868 37.9788
01-09-2026 34.3722 38.072
31-08-2026 34.7338 38.4712

Fund Launch Date: 28/Feb/2019
Fund Category: Pharma Fund
Investment Objective: The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Description: An open-ended equity scheme investing in Healthcare and Allied sectors
Fund Benchmark: BSE Healthcare- TRI
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.